Страна: США
мова: англійська
Джерело: NLM (National Library of Medicine)
GLYCOPYRROLATE (UNII: V92SO9WP2I) (GLYCOPYRRONIUM - UNII:A14FB57V1D)
Shionogi Inc.
GLYCOPYRROLATE
GLYCOPYRROLATE 1 mg
ORAL
PRESCRIPTION DRUG
For use as adjunctive therapy in the treatment of peptic ulcer. Glaucoma; obstructive uropathy (for example, bladder neck obstruction due to prostatic hypertrophy); obstructive disease of the gastrointestinal tract (as in achalasia, pyloroduodenal stenosis, etc.); paralytic ileus; intestinal atony of the elderly or debilitated patient; unstable cardiovascular status in acute hemorrhage; severe ulcerative colitis; toxic megacolon complicating ulcerative colitis; myasthenia gravis. Robinul (glycopyrrolate) tablets are contraindicated in those patients with a hypersensitivity to glycopyrrolate.
Robinul® (glycopyrrolate, 1 mg) tablets in bottles of 100 (NDC 59630-200-10). Robinul® Forte (glycopyrrolate, 2 mg) tablets in bottles of 100 (NDC 59630-205-10). Store at controlled room temperature, 20°C to 25°C (68°F to 77°F); excursions permitted to 15°-30°C (59°-86°F)[see USP Controlled Room Temperature]. Keep out of reach of children. Dispense in tight container Rx only Manufactured by: MIKART, INC. Atlanta, GA 30318 Manufactured for: Shionogi Inc. Florham Park, NJ 07932 ROB-PI-3 Rev. 12/11 Printed in USA
New Drug Application
ROBINUL- GLYCOPYRROLATE TABLET ROBINUL FORTE- GLYCOPYRROLATE TABLET SHIONOGI INC. ---------- ROBINUL AND ROBINUL FORTE DESCRIPTION Robinul and Robinul Forte tablets contain the synthetic anticholinergic, glycopyrrolate. Glycopyrrolate is a quaternary ammonium compound with the following chemical name: 3- [(cyclopentylhydroxyphenylacetyl)oxy]-1, 1-dimethylpyrrolidinium bromide. ROBINUL tablets are scored, compressed white tablets engraved HPC 200. Each tablet contains: Glycopyrrolate, USP ............................................................................................................ 1 mg ROBINUL FORTE tablets are scored, compressed white tablets engraved HORIZON 205. Each tablet contains: Glycopyrrolate, USP.............................................................................................................. 2 mg INACTIVE INGREDIENTS: Dibasic Calcium Phosphate, Lactose, Magnesium Stearate, Povidone, Sodium Starch Glycolate ACTIONS Glycopyrrolate, like other anticholinergic (antimuscarinic) agents, inhibits the action of acetylcholine on structures innervated by postganglionic cholinergic nerves and on smooth muscles that respond to acetylcholine but lack cholinergic innervation. These peripheral cholinergic receptors are present in the autonomic effector cells of smooth muscle, cardiac muscle, the sino-atrial node, the atrioventricular node, exocrine glands, and, to a limited degree, in the autonomic ganglia. Thus, it diminishes the volume and free acidity of gastric secretions and controls excessive pharyngeal, tracheal, and bronchial secretions. Glycopyrrolate antagonizes muscarinic symptoms (e.g., bronchorrhea, bronchospasm, bradycardia, and intestinal hypermotility) induced by cholinergic drugs such as the anticholinesterases. The highly polar quaternary ammonium group of glycopyrrolate limits its passage across lipid membranes, such as the blood-brain barrier, in contrast to atropine sulfate and scopolamine hydrobromide, which are non-polar tertiary amines which penetrate lipid barriers e Прочитайте повний документ